Global DNA Sequencing Reagent Market Research Report 2022

Due to the COVID-19 pandemic, the global DNA Sequencing Reagent market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe DNA Sequencing Reagent market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe DNA Sequencing Reagent landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Sanger Sequencing accounting for % of the DNA Sequencing Reagent global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Biological Research Institute segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of DNA Sequencing Reagent include Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Pacific Biosciences, Illumina, Inc., Promega Corp., LI-COR Biosciences, Oxford Nanopore Technologies, Cambrex Bio Science and Bethyl Laboratories, Inc., etc. In terms of revenue, the global 3 largest players have a % market share of DNA Sequencing Reagent in 2021.
This report focuses on DNA Sequencing Reagent volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall DNA Sequencing Reagent market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global DNA Sequencing Reagent Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Sanger Sequencing
Next Generation Sequencing
Third Generation Sequencing
Segment by Application
Biological Research Institute
Hospitals and Clinics
Pharmaceutical Institutions
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Pacific Biosciences
Illumina, Inc.
Promega Corp.
LI-COR Biosciences
Oxford Nanopore Technologies
Cambrex Bio Science
Bethyl Laboratories, Inc.
Omega Bio-Tek Inc.
MGI
BGI
NimaGen
PacBio